Patents by Inventor Mads Jellingsoe

Mads Jellingsoe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage Regimen
    Publication number: 20250090512
    Abstract: Provided herein is orismilast for use in the treatment a disease or disorder ameliorated by inhibiting PDE4 in a subject, wherein the orismilast is administered to the subject according to a specific dosage regimen. Also provided is orismilast for use the treatment of pruritus associated with atopic dermatitis.
    Type: Application
    Filed: July 31, 2024
    Publication date: March 20, 2025
    Inventors: Morten Otto Alexander SOMMER, Jakob FELDING, Kim Domela KJØLLER, Mads JELLINGSØ, Morten Lind JENSEN, Eckhard NIEMEIER
  • NICLOSAMIDE FORMULATIONS FOR TREATING DISEASE
    Publication number: 20220323384
    Abstract: The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
    Type: Application
    Filed: April 18, 2022
    Publication date: October 13, 2022
    Inventors: Morten Otto Alexander Sommer, Rasmus Toft-Kehler, Anne Katrine Toft-Kehler, Günter Ditzinger, Mads Jellingsoe, Phillippe Andres, Matthias Knopp
  • Niclosamide formulations for treating disease
    Patent number: 11324708
    Abstract: The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: May 10, 2022
    Assignee: UNION therapeutics A/S
    Inventors: Morten Otto Alexander Sommer, Rasmus Toft-Kehler, Anne Katrine Toft-Kehler, Günter Ditzinger, Mads Jellingsoe, Philippe Andres, Matthias Manne Knopp
  • Niclosamide formulations for treating disease
    Patent number: 11045434
    Abstract: The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: June 29, 2021
    Assignee: UNION therapeutics A/S
    Inventors: Morten Otto Alexander Sommer, Rasmus Toft-Kehler, Anne Katrine Toft-Kehler, Günter Ditzinger, Mads Jellingsoe, Philippe Andres, Matthias Manne Knopp